FULC - Fulcrum Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.67
DETAILS
HIGH:
$25.00
LOW:
$10.00
MEDIAN:
$23.50
CONSENSUS:
$20.67
UPSIDE:
214.61%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 0 | 80 | 2.8 | 6.3 | 19.2 | 8.8 | 0 | 0 | 0 |
| Cost of Revenue | 1.4 | 63.4 | 0 | 76.8 | 69.7 | 59.0 | 2.1 | 1.3 | 0.7 |
| Gross Profit | (1.4) | 16.6 | 2.8 | (70.4) | (50.5) | (50.2) | (2.1) | (1.3) | (0.7) |
| Operating Expenses | |||||||||
| R&D Expenses | 56.1 | 63.4 | 71.8 | 76.8 | 69.7 | 59.0 | 43.4 | 25.2 | 18.5 |
| SG&A Expenses | 28.7 | 36.4 | 41.7 | 41.7 | 30.5 | 21.4 | 13.1 | 8.3 | 4.5 |
| Other Expenses | (1.4) | (61.3) | 0 | (76.4) | (69.7) | (59.0) | 0 | 0.4 | 0.0 |
| Operating Expenses | 83.4 | 38.5 | 113.5 | 42.1 | 30.5 | 21.4 | 56.6 | 33.5 | 23.0 |
| Operating Income | |||||||||
| Operating Income | (84.8) | (21.9) | (110.7) | (112.6) | (81.1) | (71.6) | (58.6) | (33.5) | (23.0) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0.2 | 0.8 | 1.5 | 0 | 0 |
| Profitability | |||||||||
| EBITDA | (73.5) | (18.2) | (108.5) | (109.7) | (78.5) | (69.2) | (80.6) | (32.2) | (22.3) |
| EBIT | (74.9) | (19.8) | (110.7) | (112.1) | (81.1) | (71.6) | (82.7) | (33.5) | (23.0) |
| Income Before Tax | (74.9) | (9.7) | (97.3) | (109.9) | (80.8) | (70.8) | (82.7) | (32.6) | (23.0) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Net Income | (74.9) | (9.7) | (97.3) | (109.9) | (80.8) | (70.8) | (82.7) | (32.6) | (23.0) |
| Per Share Data | |||||||||
| EPS (Basic) | -1.18 | -0.16 | -1.59 | -2.35 | -2.22 | -2.70 | -3.49 | -1.92 | -1.36 |
| EPS (Diluted) | -1.18 | -0.16 | -1.59 | -2.35 | -2.22 | -2.70 | -3.49 | -1.92 | -1.36 |
| Shares Outstanding | 63.4 | 62.0 | 61.3 | 45.0 | 35.4 | 25.4 | 22.7 | 16.9 | 16.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 197.5 | 58.2 | 25.6 | 35.1 | 35.4 | 57.1 | 96.7 | 72.8 | 0.4 |
| Short-Term Investments | 154.8 | 182.8 | 210.7 | 167.8 | 182.8 | 55.9 | 0 | 0 | 0 |
| Net Receivables | 1.1 | 3.3 | 2.2 | 1.1 | 4.1 | 2.7 | 0.1 | 0.5 | 0.0 |
| Inventory | 0 | 0 | 0 | 0 | (0.5) | (2.8) | 3.0 | 0.6 | 0.7 |
| Other Current Assets | 5.2 | 0 | 0 | 0 | 0 | 0.1 | 0.3 | 0.2 | 0.2 |
| Total Current Assets | 357.5 | 249.9 | 242.2 | 207.5 | 226.0 | 112.9 | 100.1 | 74.1 | 1.3 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 7.1 | 9.6 | 12.4 | 16.0 | 7.4 | 8.4 | 87.9 | 10.5 | 2.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 0 |
| Other Non-Current Assets | 1.7 | 1.2 | 3.1 | 2.1 | 0.5 | 7.2 | (78.7) | 0.0 | 0.1 |
| Total Non-Current Assets | 8.8 | 10.8 | 15.5 | 19.2 | 9.0 | 16.7 | 10.4 | 11.7 | 3.0 |
| Total Assets | 366.3 | 260.7 | 257.7 | 226.7 | 235 | 129.6 | 110.4 | 85.8 | 4.3 |
| Current Liabilities | |||||||||
| Account Payables | 1.6 | 1.2 | 2.8 | 3.6 | 4.8 | 4.1 | 2.2 | 1.3 | 1.7 |
| Short-Term Debt | 2.4 | 0 | 0 | 2.6 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0.9 | 4.7 | 14.9 | 4.0 | 2.8 | 0 |
| Other Current Liabilities | 9.1 | 0.5 | 0.4 | 5.3 | 4.7 | 4.8 | 3.7 | 0.8 | 0.0 |
| Total Current Liabilities | 13.0 | 11.0 | 13.7 | 16.7 | 19.2 | 26.7 | 12.1 | 4.2 | 2.8 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 4.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34.6 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0.2 | 0.2 | 0.2 | 0 | 4.3 | 4.7 | 5.1 | 5.5 | (34.4) |
| Total Non-Current Liabilities | 4.2 | 6.6 | 8.8 | 11.0 | 4.3 | 7.7 | 11.1 | 5.5 | 0.2 |
| Total Liabilities | 17.3 | 17.7 | 22.5 | 27.7 | 23.5 | 34.4 | 23.3 | 9.8 | 3.0 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (594.3) | (519.4) | (509.7) | (412.3) | (302.5) | (221.6) | (150.8) | (68.1) | (35.5) |
| Accumulated Other Comprehensive Income | 0 | 0.1 | (0.1) | (0.8) | (0.4) | (0.0) | (110.4) | (2.0) | (0.9) |
| Total Stockholders' Equity | 349 | 243.0 | 235.2 | 198.9 | 211.5 | 95.2 | 87.2 | 76 | 1.3 |
| Total Liabilities & Equity | 366.3 | 260.7 | 257.7 | 226.7 | 235 | 129.6 | 110.4 | 85.8 | 4.3 |
| Debt Metrics | |||||||||
| Total Debt | 6.4 | 8.6 | 10.8 | 13.4 | 0 | 0.0 | 0.1 | 0.0 | 34.6 |
| Net Debt | (191.1) | (49.6) | (14.7) | (21.7) | (35.4) | (57.0) | (96.7) | (72.8) | 34.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | (74.9) | (9.7) | (97.3) | (109.9) | (80.8) | (70.8) | (82.7) | (32.6) | (23.0) |
| Depreciation & Amortization | 1.4 | 1.6 | 2.2 | 2.4 | 2.5 | 2.4 | 2.1 | 1.3 | 0.7 |
| Stock-Based Compensation | 12.5 | 14.6 | 14.8 | 13.3 | 11.1 | 7.3 | 4.2 | 2.2 | 1.4 |
| Change in Working Capital | 3.9 | (4.2) | (4.6) | (3.1) | (11.9) | 7.5 | 11.3 | 6.5 | 0.8 |
| Other Non-Cash Items | (3.0) | (4.4) | (6.0) | 0.2 | 0.7 | (2) | 25.6 | 4.9 | 2.6 |
| Operating Cash Flow | (60.1) | (2.2) | (91.0) | (97.0) | (78.5) | (53.7) | (39.5) | (22.6) | (20.1) |
| Investing Activities | |||||||||
| Capital Expenditure | (0.3) | (0.3) | (0.5) | (2.0) | (1.7) | (1.3) | (0.9) | (9.0) | (1.9) |
| Acquisitions | 0 | 0 | 0 | (14.4) | 128.0 | 55.8 | 0 | 0 | 0 |
| Purchases of Investments | (180.2) | (178.6) | (194.9) | (151.2) | (216.2) | (124.3) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 211.3 | 211.1 | 158.7 | 165.5 | 88.3 | 68.5 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 14.4 | (128.0) | (55.8) | (0.1) | 0 | 0 |
| Investing Cash Flow | 30.7 | 32.2 | (36.7) | 12.4 | (129.7) | (57.1) | (0.9) | (9.0) | (1.9) |
| Financing Activities | |||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | (0.0) | (0.1) | (0.0) | (0.1) | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0.8 | 3.5 | 3.7 | 1.2 | 0.2 | 0.0 | 17.7 |
| Financing Cash Flow | 168.7 | 2.7 | 118.1 | 84.3 | 186.5 | 71.1 | 64.3 | 105.0 | 17.7 |
| Cash Position | |||||||||
| Net Change in Cash | 139.3 | 32.8 | (9.5) | (0.3) | (21.6) | (39.7) | 23.9 | 73.5 | (4.3) |
| Cash at Beginning | 59.4 | 26.7 | 36.2 | 36.5 | 58.1 | 97.8 | 73.9 | 0.4 | 4.7 |
| Cash at End | 198.7 | 59.4 | 26.7 | 36.2 | 36.5 | 58.1 | 97.8 | 73.9 | 0.4 |
| Free Cash Flow | (60.4) | (2.5) | (91.5) | (99.0) | (80.2) | (55.0) | (40.3) | (31.5) | (22.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0 | 80 | 2.8 | 6.3 | 19.2 | 8.8 | 0 | 0 | 0 |
| Gross Profit | (1.4) | 16.6 | 2.8 | (70.4) | (50.5) | (50.2) | (2.1) | (1.3) | (0.7) |
| Operating Income | (84.8) | (21.9) | (110.7) | (112.6) | (81.1) | (71.6) | (58.6) | (33.5) | (23.0) |
| Net Income | (74.9) | (9.7) | (97.3) | (109.9) | (80.8) | (70.8) | (82.7) | (32.6) | (23.0) |
| EPS (Diluted) | -1.18 | -0.16 | -1.59 | -2.35 | -2.22 | -2.70 | -3.49 | -1.92 | -1.36 |
| Balance Sheet | |||||||||
| Cash & Equivalents | 197.5 | 58.2 | 25.6 | 35.1 | 35.4 | 57.1 | 96.7 | 72.8 | 0.4 |
| Total Assets | 366.3 | 260.7 | 257.7 | 226.7 | 235 | 129.6 | 110.4 | 85.8 | 4.3 |
| Total Debt | 6.4 | 8.6 | 10.8 | 13.4 | 0 | 0.0 | 0.1 | 0.0 | 34.6 |
| Stockholders' Equity | 349 | 243.0 | 235.2 | 198.9 | 211.5 | 95.2 | 87.2 | 76 | 1.3 |
| Cash Flow | |||||||||
| Operating Cash Flow | (60.1) | (2.2) | (91.0) | (97.0) | (78.5) | (53.7) | (39.5) | (22.6) | (20.1) |
| Capital Expenditure | (0.3) | (0.3) | (0.5) | (2.0) | (1.7) | (1.3) | (0.9) | (9.0) | (1.9) |
| Free Cash Flow | (60.4) | (2.5) | (91.5) | (99.0) | (80.2) | (55.0) | (40.3) | (31.5) | (22.0) |